Searchable abstracts of presentations at key conferences in endocrinology

ea0021p95 | Clinical practice/governance and case reports | SFEBES2009

Addison's disease: a new indication for continuous s.c. insulin infusion (CSII)?

Agha-Jaffar Rochan , Poulter Claire , Gable David , Robinson Stephen

Insulin induced hypoglycaemia is a life threatening complication in T1DM. Sub-optimal counter regulatory response, with hypocortisolemia, threatens the recovery from insulin induced hypoglycaemia. We present a 28-year-old man with polyglandular autoimmune syndrome type 2 and life threatening hypoglycaemia, whose severe hypoglycaemic events were improved following introduction of CSII.The patient was diagnosed with Addison’s disease in 2000 and T1DM ...